Preveceutical Medical Inc C.PREV

Alternate Symbol(s): PRVCF

PreveCeutical Medical Inc. is a Canada-based health sciences company. The Company’s principal business activity is the development of options for preventive and curative therapies utilizing organic and nature identical products. The Company’s pipeline includes Cannabinoid Sol-Gel, Non-Addictive Analgesic, BSV Peptide Program and Dual Gene Therapy. Its Cannabinoid Sol-Gel is cannabinoid-based nose-to-brain delivery system that provides relief to a range of indications from pain, inflammation, seizures, and neurological disorders. Its BSV peptide program targets cancer progression. Its Non-Addictive Analgesic is an engineering non-addictive analgesic peptide for pain management. Its Dual Gene Therapy targets type 2 diabetes and obesity. The Company’s subsidiary, PreveCeutical (Australia) Pty Ltd., manages its research programs.

CSE:PREV - Post by User

Preveceutical Medical Inc > Prev webinar tomorrow

<< Previous

Bullboard Posts

Next >>

Comment by MrQuarterson Aug 19, 2020 1:58pm

187 Views

Post# 31429644

RE:RE:RE:RE:RE:Prev webinar tomorrow

Where did you hear this? Because there was no mention of this, in fact there was only demonstrations of how they have developed a way for the spray to reach their intended area in the nasal cavity. Also I find it weird that a SOLUBLE GEL Aka SOL-GEL solidifies ....

<< Previous

Bullboard Posts

Next >>

The top TSX healthcare stocks under $1